Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.77
Delayed Data
As of Sep 23
 +0.0058 / +0.76%
Today’s Change
0.29
Today|||52-Week Range
1.17
+10.00%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.76
Today’s open0.76
Day’s range0.73 - 0.78
Volume110,788
Average volume (3 months)200,940
Market cap$109.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratio4.3
Price/Sales--
Price/Book58.16

Competitors

 Today’s
change
Today’s
% change
CTICCTi Biopharma Corp-0.01-1.28%
REPHRecro Pharma Inc+0.02+0.22%
SMMTSummit Therapeutics ...+0.13+1.51%
NEOSNeos Therapeutics In...+0.25+3.63%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Search for Jobs